Oligoclonal expansion of CD8+ TCRβ clonotypes in peri-tumoural fluid (ascites or effusion) and matched blood samples were observed in ovarian cancer and lung cancer patients [39, 52, 53]. The gene discussed is CD8A; the disease is ovarian carcinoma.